Sigma® Life Science Releases Next-Gen Sequencing Oligos

Sigma-Aldrich Corporation has announced that Sigma Life Science, its innovative biological products and services business, has released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly. These oligos are expected to allow researchers to achieve better results from multiplexing experiments.

"Sigma-Aldrich is the first oligonucleotide manufacturer to provide a cross-contamination threshold,” said Carlos Martinez, Development Manager at Sigma-Aldrich. “This gives our customers the confidence they need from the start, minimizing the time and expense created by the need to experiment with less consistent products to achieve proper sequence assembly.”

Next-generation sequencing adapters are required for the proper assembly of genome sample fragments. Adapters, especially barcode sequences, containing unacceptably low full-length sequence or excessive cross-contamination with other barcode sequences can lead to compromised sequence read integrity and improper sequence assembly. These types of problems are often undetectable until the data analysis stage, which make them costly in terms of time and money.

Sigma’s Next-Gen Sequencing Oligos are manufactured under rigorous conditions to ensure suitable purity and low levels of cross-contamination.

“With cross-contamination thresholds as low as 0.25% or less, and both ISO 9001 and 13485 manufacturing available, Next-Gen Sequencing Oligos are ideal for research, life science research tool and molecular diagnostic applications,” said Martinez.

Next-Gen Sequencing Oligos enhance Sigma Life Science’s portfolio of oligonucleotide products. For more information about Sigma Life Science’s custom oligonucleotides, visit www.sigma.com/oligos.